Home > About Zuellig

The Zuellig Group has an enviable reputation for building respected and profitable companies across the region.

By reinvesting profits where they are made, we continue to forge ahead aggressively in Asia by investing in strategic projects and partnerships that help expand our businesses.

Our strategy to achieve continued business growth is two-fold. Foremost, we remain committed to introducing initiatives across our core businesses that help grow our existing operations.

At the same time, we are continually expanding into adjacent business areas through the identification and establishment of key alliances and via acquisitions and other key investments that complement our core areas of expertise.
Latest news
Aug 2008
The Zuellig Group announces purchase of Symbion Pharmacy
Aug 2007
The Zuellig Group announces the sale of PRNZ
July 2006
Gold Coin Group and Godrej Agrovet agree to form joint venture
May 2006
The Zuellig Group announces purchase of Powerlift in Australia
Mar 2006
Interview of Gold Coin Group's new CEO, JC Filippi
Jun 2005
Interpharma, Quintiles and Temasek to Form Pharma Commercialisation Joint Venture in Asia Pacific